Washington HB1326 mandates health plans to cover obesity treatment, including lifestyle interventions, surgery, and FDA-approved medications.
Washington HB1326 requires health plans to cover the treatment of obesity as a chronic disease, including intensive health behavioral and lifestyle treatment, metabolic and bariatric surgery, and FDA-approved obesity medications. The bill mandates that coverage criteria for FDA-approved obesity medications cannot be more restrictive than the FDA-approved indications for those treatments. It also ensures that coverage for obesity treatment is not different from coverage for any other illness, condition, or disorder for purposes of determining deductibles, copayment, and coinsurance factors.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.